Q3 2020 13F Holders as of 9/30/2020
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
142M
-
Number of holders
-
62
-
Total 13F shares, excl. options
-
12.2M
-
Shares change
-
+540K
-
Total reported value, excl. options
-
$253M
-
Value change
-
-$3.37M
-
Number of buys
-
29
-
Number of sells
-
-35
-
Price
-
$20.76
Significant Holders of Applied Therapeutics, Inc. - COMMON STOCK (APLT) as of Q3 2020
81 filings reported holding APLT - Applied Therapeutics, Inc. - COMMON STOCK as of Q3 2020.
Applied Therapeutics, Inc. - COMMON STOCK (APLT) has 62 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 12.2M shares
of 142M outstanding shares and own 8.61% of the company stock.
Largest 10 shareholders include FMR LLC (2.33M shares), ORBIMED ADVISORS LLC (1.55M shares), Rock Springs Capital Management LP (992K shares), BlackRock Inc. (828K shares), ALKEON CAPITAL MANAGEMENT LLC (738K shares), Knoll Capital Management, LP (735K shares), VANGUARD GROUP INC (681K shares), DRIEHAUS CAPITAL MANAGEMENT LLC (627K shares), EMERALD ADVISERS, LLC (505K shares), and EMERALD MUTUAL FUND ADVISERS TRUST (504K shares).
This table shows the top 62 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.